Kumar B Rajan1, Elizabeth A McAninch2, Robert S Wilson3,4,5, Jennifer Weuve6, Lisa L Barnes3,4,5, Denis A Evans2. 1. Department of Public Health Sciences, UC Davis, Davis, CA, USA. 2. Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA. 3. Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA. 4. Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA. 5. Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA. 6. Department of Epidemiology, Boston University, Boston, MA, USA.
Abstract
BACKGROUND: The association of the APOEɛ4 allele with incident Alzheimer's dementia is higher among European Americans (EAs) than African Americans (AAs), but similar for the rate of cognitive decline. OBJECTIVE: To examine the racial differences in the association of the APOEɛ4 allele with incident Alzheimer's dementia and cognitive decline. METHODS: Using a population-based sample of 5,117 older adults (66% AAs and 63% females), we identified cognitive trajectory groups from a latent class mixed model and examined the association of the APOEɛ4 allele with these groups. RESULTS: The frequency of the APOEɛ4 allele was higher among AAs than EAs (37% versus 26%). Four cognitive trajectories were identified: slow, mild, moderate, and rapid. Overall, AAs had a lower baseline global cognition than EAs, and a higher proportion had rapid (7% versus 5%) and moderate (20% versus 15%) decline, but similar mild (44% versus 46%), and lesser slow (29% versus 34%) decline compared to EAs. Additionally, 25% of AAs (13% of EAs) with mild and 5% (<1% of EAs) with slow decline were diagnosed with incident Alzheimer's dementia. The APOEɛ4 allele was associated with higher odds of rapid and moderate decline compared to slow decline among AAs and EAs, but not with mild decline. CONCLUSIONS: AAs had lower cognitive levels and were more likely to meet the cognitive threshold for Alzheimer's dementia among mild and slow decliners, explaining the attenuated association of the ɛ4 allele with incident Alzheimer's dementia among AAs.
BACKGROUND: The association of the APOEɛ4 allele with incident Alzheimer's dementia is higher among European Americans (EAs) than African Americans (AAs), but similar for the rate of cognitive decline. OBJECTIVE: To examine the racial differences in the association of the APOEɛ4 allele with incident Alzheimer's dementia and cognitive decline. METHODS: Using a population-based sample of 5,117 older adults (66% AAs and 63% females), we identified cognitive trajectory groups from a latent class mixed model and examined the association of the APOEɛ4 allele with these groups. RESULTS: The frequency of the APOEɛ4 allele was higher among AAs than EAs (37% versus 26%). Four cognitive trajectories were identified: slow, mild, moderate, and rapid. Overall, AAs had a lower baseline global cognition than EAs, and a higher proportion had rapid (7% versus 5%) and moderate (20% versus 15%) decline, but similar mild (44% versus 46%), and lesser slow (29% versus 34%) decline compared to EAs. Additionally, 25% of AAs (13% of EAs) with mild and 5% (<1% of EAs) with slow decline were diagnosed with incident Alzheimer's dementia. The APOEɛ4 allele was associated with higher odds of rapid and moderate decline compared to slow decline among AAs and EAs, but not with mild decline. CONCLUSIONS: AAs had lower cognitive levels and were more likely to meet the cognitive threshold for Alzheimer's dementia among mild and slow decliners, explaining the attenuated association of the ɛ4 allele with incident Alzheimer's dementia among AAs.
Authors: Jeannie-Marie S Leoutsakos; Sarah N Forrester; Christopher D Corcoran; Maria C Norton; Peter V Rabins; Martin I Steinberg; Joann T Tschanz; Constantine G Lyketsos Journal: Int J Geriatr Psychiatry Date: 2014-11-03 Impact factor: 3.485
Authors: R S Wilson; D A Bennett; J L Bienias; N T Aggarwal; C F Mendes De Leon; M C Morris; J A Schneider; D A Evans Journal: Neurology Date: 2002-12-24 Impact factor: 9.910
Authors: R S Wilson; D A Bennett; L A Beckett; M C Morris; D W Gilley; J L Bienias; P A Scherr; D A Evans Journal: J Gerontol B Psychol Sci Soc Sci Date: 1999-05 Impact factor: 4.077
Authors: Hal H Atkinson; Matteo Cesari; Stephen B Kritchevsky; Brenda W J H Penninx; Linda P Fried; Jack M Guralnik; Jeff D Williamson Journal: J Am Geriatr Soc Date: 2005-07 Impact factor: 5.562
Authors: Patricia A Wilkosz; Howard J Seltman; Bernie Devlin; Elise A Weamer; Oscar L Lopez; Steven T DeKosky; Robert A Sweet Journal: Int Psychogeriatr Date: 2009-09-28 Impact factor: 3.878
Authors: Julia L Bienias; Laurel A Beckett; David A Bennett; Robert S Wilson; Denis A Evans Journal: J Alzheimers Dis Date: 2003-10 Impact factor: 4.472
Authors: L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn Journal: JAMA Date: 1997 Oct 22-29 Impact factor: 56.272
Authors: Kacie D Deters; Elizabeth C Mormino; Lei Yu; Michael W Lutz; David A Bennett; Lisa L Barnes Journal: Alzheimers Dement Date: 2021-02-13 Impact factor: 21.566
Authors: May A Beydoun; Jordan Weiss; Hind A Beydoun; Sharmin Hossain; Ana I Maldonado; Botong Shen; Michele K Evans; Alan B Zonderman Journal: Alzheimers Res Ther Date: 2021-06-30 Impact factor: 6.982
Authors: Jordan Weiss; Sharmin Hossain; Ana I Maldonado; Botong Shen; Hind A Beydoun; Mika Kivimaki; Michele K Evans; Alan B Zonderman; May A Beydoun Journal: Sci Rep Date: 2021-10-06 Impact factor: 4.996
Authors: Phazha L K Bothongo; Mark Jitlal; Eve Parry; Sheena Waters; Isabelle F Foote; Cameron J Watson; Jack Cuzick; Gavin Giovannoni; Ruth Dobson; Alastair J Noyce; Naaheed Mukadam; Jonathan P Bestwick; Charles R Marshall Journal: Lancet Reg Health Eur Date: 2022-02-11
Authors: Klodian Dhana; Lisa L Barnes; Xiaoran Liu; Puja Agarwal; Pankaja Desai; Kristin R Krueger; Thomas M Holland; Shannon Halloway; Neelum T Aggarwal; Denis A Evans; Kumar B Rajan Journal: Alzheimers Dement Date: 2021-07-26 Impact factor: 16.655
Authors: Anna Vasilevskaya; Foad Taghdiri; Charles Burke; Apameh Tarazi; Seyed Ali Naeimi; Mozghan Khodadadi; Ruma Goswami; Christine Sato; Mark Grinberg; Danielle Moreno; Richard Wennberg; David Mikulis; Robin Green; Brenda Colella; Karen D Davis; Pablo Rusjan; Sylvain Houle; Charles Tator; Ekaterina Rogaeva; Maria C Tartaglia Journal: Neuroimage Clin Date: 2020-02-13 Impact factor: 4.881